Production (Stage)
Apyx Medical Corporation
APYX
$1.54
-$0.12-7.23%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 9.43M | 14.22M | 11.49M | 12.15M | 10.24M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.43M | 14.22M | 11.49M | 12.15M | 10.24M |
| Cost of Revenue | 3.77M | 5.26M | 4.53M | 4.66M | 4.30M |
| Gross Profit | 5.67M | 8.96M | 6.95M | 7.49M | 5.95M |
| SG&A Expenses | 7.91M | 10.90M | 9.45M | 11.62M | 11.17M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.48M | 17.27M | 15.12M | 17.70M | 16.86M |
| Operating Income | -3.05M | -3.05M | -3.64M | -5.55M | -6.62M |
| Income Before Tax | -4.12M | -4.57M | -4.66M | -6.54M | -7.54M |
| Income Tax Expenses | 49.00K | 89.00K | 60.00K | 50.00K | 53.00K |
| Earnings from Continuing Operations | -4.17M | -4.66M | -4.72M | -6.59M | -7.59M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 22.00K | 31.00K | 21.00K | 30.00K | 14.00K |
| Net Income | -4.15M | -4.63M | -4.70M | -6.56M | -7.58M |
| EBIT | -3.05M | -3.05M | -3.64M | -5.55M | -6.62M |
| EBITDA | -2.91M | -2.91M | -3.49M | -5.39M | -6.46M |
| EPS Basic | -0.10 | -0.12 | -0.14 | -0.19 | -0.22 |
| Normalized Basic EPS | -0.06 | -0.07 | -0.08 | -0.12 | -0.14 |
| EPS Diluted | -0.10 | -0.12 | -0.14 | -0.19 | -0.22 |
| Normalized Diluted EPS | -0.06 | -0.07 | -0.08 | -0.12 | -0.14 |
| Average Basic Shares Outstanding | 40.73M | 38.22M | 34.64M | 34.64M | 34.64M |
| Average Diluted Shares Outstanding | 40.73M | 38.22M | 34.64M | 34.64M | 34.64M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |